CareLit · DOI-Nachweis · Pneumologie
Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen
DOI 10.1055/s-2008-1074239
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ von Pawel, M Reck, R Ramlau, J Jassem, P Zatloukal, O Hansen, X Sun
ZeitschriftPneumologie
Ausgabe04/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Vinfluine (VFL) is a new microtubule inhibitor of the vinca alkaloid class with clinical activity in NSCLC. Single-agent efficacy and safety of VFL and docetaxel (DTX) were compared in the 2nd line chemotherapy. Methods: Open-label, multi-center randomised, phase III study in platinum pre-treated locally advanced/metastatic NSCLC pts. At least 275 pts were to be randomized by arm to receive VFL/320mg/m2,…
Zitieren
Zitierempfehlung
J von Pawel, M Reck, R Ramlau, J Jassem, P Zatloukal, O Hansen, X Sun (2008) Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen. Pneumologie (04). https://doi.org/10.1055/s-2008-1074239
Mit CareLit weiterarbeiten